Doctor profile · Federal record

Dr. Matthew Laroe, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Midlothian, VA

  • NPI 1598290454
  • Accepts Medicare
  • 9 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
348 Browns Hill CT
Midlothian, VA 231149511
(804) 272-2702
fax (804) 272-9355

Credentials & registration

NPPES · NUCC
NPI registered
April 2017 — 9 yrs on file
Profile last updated
February 27, 2023
Year of graduation
2017 — 9 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Virginia #0101275228

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1598290454. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,866
Distinct HCPCS
10
Medicare allowed
$228,891
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 2,160 24 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 835 390 $124
99215 Established patient office or other outpatient visit, 40-54 minutes 266 266 $175
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 190 79 $34
82962 Blood glucose (sugar) test performed by hand-held instrument 186 120 $3
77080 Dxa bone density measurement of hip, pelvis, spine 67 67 $37
99205 New patient office or other outpatient visit, 60-74 minutes 63 63 $208
96372 Injection of drug or substance under skin or into muscle 42 25 $14
76536 Ultrasound scan of head and neck soft tissue 35 35 $111
99213 Established patient office or other outpatient visit, 20-29 minutes 22 22 $88

In context: peer comparison

Among 7 peers in Midlothian Endocrinology, Diabetes & Metabolism Physician, average services per provider: 321. This provider delivers 12× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,507
Transactions
93
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Insulet Corporation 7 $675.39
Lilly USA, LLC 21 $372.42
Novo Nordisk INC 24 $336.45
Sanofi-Aventis U.S. LLC 6 $146.29
Abbott Laboratories 5 $97.38
Xeris Pharmaceuticals, INC. 4 $84.35
Novartis Pharmaceuticals Corporation 4 $81.87
Radius Health, INC. 3 $77.04
Boehringer Ingelheim Pharmaceuticals, INC. 4 $73.89
Antares Pharma, INC. 3 $58.60
Amneal Pharmaceuticals LLC 3 $54.56
Tolmar, INC. 3 $45.69
Ibsa Pharma INC. 2 $43.99
Pfizer INC. 2 $41.77
Mannkind Corporation 2 $41.54

By nature of payment

Food and Beverage
$2,507

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,093
Patients
692
Total drug cost
$879,561
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 364 124 $5,833
Metformin Hcl ER (Metformin Hcl) Brand 227 80 $3,593
Glimepiride Generic 200 66 $3,759
Ozempic (Semaglutide) Brand 183 52 $320,613
Atorvastatin Calcium Generic 153 56 $2,863
Rosuvastatin Calcium Generic 128 47 $3,621
Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) Brand 125 48 $123,941
Synthroid (Levothyroxine Sodium) Brand 120 40 $11,173
Jardiance (Empagliflozin) Brand 113 41 $165,147
Methimazole Generic 105 32 $1,285

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Matthew Laroe's medical specialty?
Dr. Matthew Laroe practices Endocrinology, Diabetes & Metabolism Physician in Midlothian, VA.
Where does Dr. Matthew Laroe practice?
Dr. Matthew Laroe practices at 348 Browns Hill CT, Midlothian, VA 231149511. Office phone: 8042722702.
What is Dr. Matthew Laroe's NPI?
Dr. Matthew Laroe's National Provider Identifier (NPI) is 1598290454, issued by NPPES.
Does Dr. Matthew Laroe accept Medicare assignment?
Yes. Dr. Matthew Laroe accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Laroe commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.